Latest California Healthline Stories
Biosimilars, Biologics And New Legal Challenges For RA Treatments
As biosimilar products reach the market and rival more established RA treatments, the players are exploring legal challenges involving antitrust and anti-competitive behavior.
Unregulated Herpes Experiments Expose ‘Black Hole’ Of Accountability
Controversial research methods by university researcher unlikely to prompt federal response or institutional change, experts say.
Pharmacists Slow To Dispense Lifesaving Overdose Drug
Laws in California and most other states allow pharmacists to provide naloxone to patients or their friends without a doctor’s prescription. But many don’t do so, citing lack of demand and awareness among patients, their own fears of insufficient compensation and the challenges of treating opioid users.
Doing More Harm Than Good? Epidemic of Screening Burdens Nation’s Older Patients
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.
No Sweeteners Added To Tax Bill To Spread Use Of Health Savings Accounts
These accounts are exempt from taxes and linked to high-deductible health plans. Republicans tried last summer in their unsuccessful efforts to replace the health law to make the accounts more enticing for consumers, but they didn’t make those changes in the current tax bill.
Drug Industry Spent Millions To Squelch Talk About High Drug Prices
Last year, the pharma industry’ biggest trade group raised millions to change the conversation about drug pricing.
If Your Insurer Covers Few Therapists, Is That Really Mental Health Parity?
Behavioral care was at least four times more likely to be out-of-network than medical or surgical care, an analysis by Milliman shows.
Stopping Opioid Addiction At One Key Source: The Hospital
Based on research conducted at the University of Michigan’s medical center, a group of surgeons developed a strategy to help post-surgical patients from misusing or abusing their prescription painkillers.
Your Plumber Offers A Money-Back Guarantee. Should Your Doctor?
Even though consumers don’t expect to pay for faulty service or goods, they are often forced to pay for bad health care. But a small number of hospitals and doctors are seeking to change that practice.
CVS-Aetna Merger A Bid To Bring Down Costs, Gain Competitive Edge
What will the mega-merger mean for consumers and the health care industry? Senior correspondent Chad Terhune offers insight.